(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MYOVANT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MYOVANT

ST13

US500000088254852

Class

42

Filing

88254852

Registration

5987695

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

02/18/2025

Trademark type

Word

Nice classes

42

Filing date

01/09/2019

Registration date

02/18/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/18/2020

Last transaction

02/18/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

4

Owner type

27

Owner location

BASEL, CH

Examiner

MACFARLANE, JAMES

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

SUMITOMO PHARMA SWITZERLAND GMBH
Myovant Sciences GmbH

Representatives

Joyce M. Ferraro FROSS ZELNICK LERHMAN & ZISSU, P.C.

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Scientific and technological servicesmedical researchscientific research and analysistechnological consulting in the fields of pharmaceuticalsbiomedicineclinical trials for others and post-market trials for others; pharmaceuticalbiomedical and biological therapeutic research services; research in the fields of pharmaceutical and biologic therapeutic preparationsclinical trials for others and post-market trials for others; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticalsbiomedicineclinical trials and post-market trials

Publications

History of USPTO decisions and trademark events.

26 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

02/18/2025

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

12/13/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/26/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/26/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/26/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/26/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/26/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

02/18/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/03/2019

PUBO

PUBLISHED FOR OPPOSITION

12/03/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/13/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/25/2019

XAEC

EXAMINER'S AMENDMENT ENTERED

10/25/2019

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

10/25/2019

GNEA

EXAMINERS AMENDMENT E-MAILED

10/25/2019

CNEA

EXAMINERS AMENDMENT -WRITTEN

10/25/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/10/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/10/2019

ALIE

ASSIGNED TO LIE

10/07/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/29/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/28/2019

GNRT

NON-FINAL ACTION E-MAILED

03/28/2019

CNRT

NON-FINAL ACTION WRITTEN

03/28/2019

DOCK

ASSIGNED TO EXAMINER

03/25/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/30/2019

NWAP

NEW APPLICATION ENTERED

01/12/2019

Continuous trademark protection

Get notified about every new filing that threatens MYOVANT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.